Two Brain & Behavior Research Foundation Scientific Council Members have announced promising results of clinical trials of a ketamine-alternative called BCI-838 for the treatment of depression. Ketamine works within...
- Mental Illnesses
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
You are hereDiscoveries ›
Next Generation Therapies
Elevated levels of a class of hormones called glucocorticoids have long been linked to anxiety disorders and depression. It is known that the presence of too much of these hormones mediates what we call ‘stress’ and that...
Brain & Behavior Research Foundation Scientific Council Member Richard Keefe, Ph.D., Director of the Schizophrenia Research Group at the Duke Institute for Brain Sciences, is one of the leaders of a multi-center...
NARSAD Distinguished Investigator Grantee, James F. Leckman, M.D., professor of Pediatrics and Psychiatry at the Yale University Child Study Center, is one of the researchers talking part in an ongoing, large-scale study...
Two-time NARSAD Young Investigator Grantee, Olivier Berton, Ph.D., assistant professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania and a team of researchers have shown that the...